A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients - Concepedia

Concepedia

Publication | Open Access

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

DOI Full Paper Access

70

Citations

25

References

2019

Year

Roy F. Chemaly, Sanjeet Dadwal, Anne Bergeron, Per Ljungman, Yae‐Jean Kim, Guang‐Shing Cheng, Sudhakar Pipavath, Ajit P. Limaye, Élodie Blanchard, Drew J. Winston,

Clinical Infectious Diseases

Abstract

NCT02254408; EUDRA-CT#2014-002474-36.

References

	Year	Citations

Page 1